Valuation: SMS Pharmaceuticals Limited

Market Cap 44.48B 464M 408M 385M 351M 657M 661M 4.6B 1.78B 22.71B 1.74B 1.71B 73.03B P/E 2025
27.3x
P/E 2026 33.6x
Enterprise Value 47.68B 498M 437M 412M 376M 704M 708M 4.93B 1.91B 24.34B 1.87B 1.83B 78.27B EV / Sales 2025
2.75x
EV / Sales 2026 4.31x
Free-Float
23.41%
Yield 2025
0.19%
Yield 2026 0.11%
1 day+0.06%
1 week+7.20%
Current month+27.79%
1 month+33.16%
3 months+26.21%
6 months+17.67%
Current year+53.10%
1 week 445
Extreme 445
494.4
1 month 349.95
Extreme 349.95
494.4
Current year 293.55
Extreme 293.55
494.4
1 year 240.45
Extreme 240.45
494.4
3 years 111.95
Extreme 111.95
494.4
5 years 54.5
Extreme 54.5
494.4
10 years 23.55
Extreme 23.55
494.4
Manager TitleAgeSince
Chief Executive Officer 66 29/08/1990
Director of Finance/CFO - 12/09/2017
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 66 29/08/1990
Director/Board Member 38 04/06/2020
Director/Board Member 48 28/05/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.06%+7.20% - - 464M
+0.12%+0.81%+13.81%+64.78% 46.37B
+1.09%+0.36%+39.50%+107.67% 37.26B
+2.00%+3.78%+18.12%+99.54% 12.53B
+0.05%+0.37%-7.29%+18.68% 11.8B
0.00%0.00%+18.72%+139.63% 8.97B
-1.34%-2.73%+27.67%+37.52% 7.09B
-2.07%-2.75%+17.20%+202.97% 7.01B
+1.43%+2.22%+43.10%-14.21% 7.29B
-2.45%-0.59%-51.49%+4.53% 4.99B
Average -0.11%+0.16%+13.26%+73.46% 15.92B
Weighted average by Cap. +0.32%+0.54%+19.51%+79.15%

Financials

2025 2026
Net sales 7.83B 81.69M 71.72M 67.66M 61.7M 116M 116M 810M 313M 4B 307M 300M 12.85B 8.89B 92.74M 81.43M 76.81M 70.04M 131M 132M 919M 356M 4.54B 348M 341M 14.59B
Net income 691M 7.21M 6.33M 5.98M 5.45M 10.21M 10.27M 71.53M 27.67M 353M 27.09M 26.5M 1.14B 1.02B 10.64M 9.35M 8.82M 8.04M 15.06M 15.16M 106M 40.83M 521M 39.96M 39.09M 1.67B
Net Debt 2.69B 28.1M 24.67M 23.28M 21.22M 39.75M 40.01M 279M 108M 1.37B 106M 103M 4.42B 3.19B 33.3M 29.24M 27.58M 25.15M 47.11M 47.41M 330M 128M 1.63B 125M 122M 5.24B
Logo SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.
Employees
1,617
Date Price Change Volume
25/09/26 ₹474.85 +0.06% 45,708
24/09/26 ₹474.55 -1.71% 19,896
23/09/26 ₹482.80 -0.03% 44,864
22/09/26 ₹482.95 +3.54% 74,560
21/09/26 ₹466.45 +5.31% 79,722

Annual profits - Rate of surprise